JPRN-UMIN000001016
Completed
未知
Trial for in vitro screening of cytotoxic T lymphocyte induction with use of allogeneic dendritic cells for patients with pleural or peritoneal carcinomatosis - In vitro screening of CTL induction by allogeneic dendritic cells for pleural or peritoneal carcinomatosis
Division of Gastrointestinal Surgery, Kobe University Hospital0 sites100 target enrollmentFebruary 5, 2008
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Peritoneal or pleural carcinomatosis (carcinomas of the stomach, colorectum, biliary duct, pancreas, uterus, ovary, kidney, lung or malignant melanoma etc.) and malignant mesothelioma
- Sponsor
- Division of Gastrointestinal Surgery, Kobe University Hospital
- Enrollment
- 100
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Active double cancer. 2\) Exclude the patients who have serious illness or suspect to have serious illness. 3\) Myocardial infarction or unstable angina, occurred within 6 months. 4\) Psychosis. 5\) Women during pregnancy or breast\-feeding. 6\) Previous history of severe drug\-induced allergy. 7\) Exclude the patients who are recognized as inadequate patients by doctors with responsibility in this trial.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Investigation of drug specific cytotoxic T cell in severe cutaneous adverse drug reactioJPRN-UMIN000009708Yokohama City University Graduate School of Medicine10
Unknown
Phase 1
Clinical Safety and Preliminary Efficacy of AAV-DC-CTL Treatment in Stage IV Gastric CancerStage IV Gastric CancerNCT01637805Tianjin Medical University Cancer Institute and Hospital30
Active, not recruiting
Phase 1
Phase I/II clinical trial of T cell suicide gene therapy following haploidentical stem cell transplantatioEUCTR2005-001925-27-GBGreat Ormond Street Hospital For Children NHS Trust10
Active, not recruiting
Phase 1
Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and AsiaYellow feverMedDRA version: 20.0Level: PTClassification code: 10048240Term: Yellow fever Class: 100000004862Therapeutic area: Diseases [C] - Virus Diseases [C02]CTIS2022-502047-35-00Sanofi Pasteur690
Active, not recruiting
Phase 1
Study on an Investigational Yellow Fever Vaccine Compared with Stamaril in Adults in Europe and AsiaEUCTR2020-005566-33-DESanofi Pasteur690